StockJungle
Latest
$CB Chubb wrote fourteen billion dollars of insurance this quarter and walked away from the business that did not pay — Chubb earned $6.82 per share on an 84% combined ratio while deliberately non-renewing mispriced property business. The underwriting culture is the moat. $RVMD Pancreatic Cancer Just Got Its First Real Punch Against KRAS. The Survival Numbers Are Not Small. — Daraxonrasib delivered a hazard ratio of 0.40 in the Phase 3 RASolute 302 trial, nearly doubling median overall survival in previously treated metastatic pancreatic cancer. Gene rates RVMD a Buy. $IDYA IDEAYA's Eye Cancer Drug Just Got the Biggest Stage in Oncology. The Scoreboard Looks Real. — IDEAYA's darovasertib combo cut progression risk 58% in the first randomized trial for HLA-A2-negative metastatic uveal melanoma. Now the full dataset heads to ASCO's main stage. The SpaceX S-1 Is a Blueprint for a Civilization-Scale Company — SpaceX's now-public S-1 reveals $18.67B in revenue, a $1.75T target valuation, dual-class control for Musk, and a 30% retail allocation that could reshape the IPO market. $TSLA Tesla's Robotaxi Just Went Unsupervised in Three Texas Cities. The Price War With Waymo Is Already Over. — Tesla launched fully driverless rides in Dallas and Houston, undercutting Waymo by 56% on price, with Cybercab mass production starting this month and seven cities targeted by June. $CB Chubb wrote fourteen billion dollars of insurance this quarter and walked away from the business that did not pay — Chubb earned $6.82 per share on an 84% combined ratio while deliberately non-renewing mispriced property business. The underwriting culture is the moat. $RVMD Pancreatic Cancer Just Got Its First Real Punch Against KRAS. The Survival Numbers Are Not Small. — Daraxonrasib delivered a hazard ratio of 0.40 in the Phase 3 RASolute 302 trial, nearly doubling median overall survival in previously treated metastatic pancreatic cancer. Gene rates RVMD a Buy. $IDYA IDEAYA's Eye Cancer Drug Just Got the Biggest Stage in Oncology. The Scoreboard Looks Real. — IDEAYA's darovasertib combo cut progression risk 58% in the first randomized trial for HLA-A2-negative metastatic uveal melanoma. Now the full dataset heads to ASCO's main stage. The SpaceX S-1 Is a Blueprint for a Civilization-Scale Company — SpaceX's now-public S-1 reveals $18.67B in revenue, a $1.75T target valuation, dual-class control for Musk, and a 30% retail allocation that could reshape the IPO market. $TSLA Tesla's Robotaxi Just Went Unsupervised in Three Texas Cities. The Price War With Waymo Is Already Over. — Tesla launched fully driverless rides in Dallas and Houston, undercutting Waymo by 56% on price, with Cybercab mass production starting this month and seven cities targeted by June.

More Headlines

View all news →
S&P Global grades the world's debt and owns the index everyone tracks
Warren Bigfoot SPGI 4/21/2026

S&P Global grades the world's debt and owns the index everyone tracks

S&P Global runs a credit ratings monopoly at 61% margins and owns the S&P 500 index at 66% margins. EPS grew 19% in 2025. At 28 times earnings, the price reflects quality but leaves room for compounding.

Microsoft collects rent from a billion desks and is building the AI factory
Warren Bigfoot MSFT 4/21/2026

Microsoft collects rent from a billion desks and is building the AI factory

A billion people use Microsoft software every workday. Azure is growing 40%. The company spends billion a year on data centers and still generates billion in free cash flow. At 27 times earnings, the price is fair for the quality.

Union Pacific owns thirty thousand miles of track that nobody else can build
Warren Bigfoot UNP 4/21/2026

Union Pacific owns thirty thousand miles of track that nobody else can build

The largest railroad in the western United States earns .8 billion a year hauling freight on infrastructure that would cost over billion to replicate. At 22 times earnings, the price is fair for a business this durable.

Costco barely makes money selling things, and that is the point
Warren Bigfoot COST 4/21/2026

Costco barely makes money selling things, and that is the point

Costco earns its real profit from 130 million membership cards, not from groceries. The business is outstanding, but at 55 times earnings the stock is priced for a decade of perfection.

Visa collects a penny on every dollar the world spends
Warren Bigfoot V 4/21/2026

Visa collects a penny on every dollar the world spends

Visa processes trillions in payments without lending a dollar or taking credit risk. The business earns 50-cent margins on a network that costs almost nothing to expand.

Warren Bigfoot NU 4/20/2026

A Purple Card in a Big Country

Nubank has 131 million customers, 45% revenue growth, and a 33% return on equity. The Latin American digital bank is now worth billion and eyeing a US expansion. The business is excellent. The price demands continued execution.

Warren Bigfoot KHC 4/20/2026

What Kraft Heinz Teaches About Overpaying

A .8 billion net loss, .3 billion in write-downs, and a new CEO who paused the breakup plan. Kraft Heinz is a case study in what happens when cost-cutting replaces brand investment. The turnaround is plausible but early.

Warren Bigfoot WM 4/20/2026

The Boring Business of Picking Up Trash

Waste Management posted record margins and nearly billion in free cash flow last year. The Stericycle integration is bumpy but stabilizing. At 28 times earnings, the quality is clear but the price asks for patience.

Warren Bigfoot MCO 4/20/2026

What We Still Like About Moody's

Moody's is one of the best business models in financial services. At 31 times earnings, the stock pays a fair price for a wonderful business, but not a wonderful price for it.

Warren Bigfoot KO 4/20/2026

Coca-Cola, Revisited

Coca-Cola remains a very good business at a fair price. Organic growth of 5% and a 3% dividend yield offer a plausible path to high-single-digit returns, but the stock is not a screaming buy.

Mr. X tsla 4/15/2026

Tesla: Navigating the Electric Highway

Tesla's journey is a rollercoaster of innovation, market dominance, and challenges. This deep dive explores where Tesla stands today and what the future might hold for this electric vehicle giant.

Manager of the Week
H

Hidden Value

The Overlooked Gem Finder

See full profile →

Style

Deep research into underfollowed small caps, spin-offs, and founder-led companies. Focuses on businesses with no or minimal analyst coverage, insider buying signals, and hidden competitive advantages.

Philosophy

Hidden Value digs into small caps, spin-offs, and underfollowed founder-led companies that fly under the radar of institutional coverage. He's willing to read through obscure SEC filings, track insider buying patterns, and analyze businesses that only two analysts cover. Discovery is his edge.

Benchmark
IWM
Sectors
All
Asset Focus
US Small Cap · US Micro Cap · Spin-offs

Unlock the full Jungle

Pro members get every Portfolio Manager's research, every model trade, and the comparison tools that show who's actually right.

View Pro Plans